First Majestic Silver Sees BMO Resume Coverage With $13.25 Price Target

On November 30th, First Majestic Silver Corp. (TSX: FR) priced their convertible senior notes due in 2027. The company announced that it will be issuing US$200 million in notes. The notes will bear a cash interest semi-annually at 0.375% per annum and the conversion will be 60.3865 common shares per US$100 principal. The company said it intends to use C$164.9 million to repurchase $125.2 million aggregate principal of its 1.875% convertible senior note.

First Majestic Silver currently has 5 analysts covering the stock with an average 12-month price target of C$20.34, or a 46% upside to the current stock price. Out of the 5 analysts, 2 analysts have to buy ratings and 3 have hold ratings. The street high sits at C$31.27 from H.C Wainwright while the lowest price target sits at C$13.25.

After the news, BMO Capital Markets resumed their coverage of First Majestic Silver with a C$13.25 price target, lowering it from the C$13.75 they had on the company beforehand. They also reiterated their market performance rating on the stock.

BMO says that they had a period of research restriction due to the senior note offering but since the deal has been priced they are now able to resume. They add that after using $164.9 million of the proceeds to repurchase the existing 1.875% notes, those notes will have roughly $31.1 million remaining and expect the remaining to be converted into 3.3 million shares.

Below you can see the updated BMO’s updated.


Information for this briefing was found via Sedar and Refinitiv. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

When 4% of Global Copper Disappears Overnight | David Gower – Emerita Resources

Mining M&A: Gold X2 Acquires Kesselrun Resources

They Said Oil Was Dead. They Were Wrong. | Michael Judson – Record Resources

Recommended

First Majestic Posts Record Quarterly Silver Production In Q3

Nord Precious Metals Produces High Grade Silver Concentrate From Tailings

Related News

Medipharm Labs Receives Price Target Reduction From Canaccord To $1.75

Yesterday, On November 16th, Medipharm Labs (TSX: LABS) reported their third quarter financial results. Reported...

Tuesday, November 17, 2020, 03:37:00 PM

Tilray: Canaccord Lowers Target On Expected Adult-Use Sales Slump, Revised Hexo Deal

Earlier this week, Tilray Brands (TSX: TLRY) announced an update to their strategic alliance with...

Friday, June 17, 2022, 10:49:29 AM

Well Health: Canaccord Slashes Price Target To $6

On May 11th, WELL Health Technologies Corp. (TSX: WELL) reported its first quarter financial results....

Wednesday, May 25, 2022, 04:11:00 PM

Green Thumb: Analysts Raise Targets Following Strong Q1 Results

Green Thumb Industries Inc. (CSE: GTII) reported their first quarter financials after market close on...

Saturday, May 15, 2021, 01:41:00 PM

Cresco Labs: Stifel Slashes Price Target From $30 To $8 Following Poor Q4 Results

On March 23rd, Cresco Labs (CSE: CL) announced its fourth-quarter financial results, which disappointed many...

Friday, March 25, 2022, 03:39:00 PM